EXERCISE PROGRAM FOR THE PREVENTION OF OSTEOPOROTIC FRACTURE
With
Belinda Beck,
Professor of Exercise Science,
Griffith University &
Owner and Director, The Bone Clinic &
Member of Medical and Scientific Advisory Committee
Healthy Bones Australia (formerly Osteoporosis Australia)
RESEARCHER PROFILE
Filmed in Southport, Queensland, Australia | May 2025
Dr Beck is an international leader in the effects of mechanical loading on bone health. Dr Beck graduated from The University of Queensland (BHMS[Ed]) and the University of Oregon (MSc and PhD) and completed a postdoctoral research fellowship in the Stanford University School of Medicine (California, USA.) She is a Professor of Exercise Science at Griffith University Gold Coast campus, where she has led the Bone Densitometry Research Laboratory since 2004.
Dr Beck has been awarded $7.6M in research grant funding to work on both animal and human models, from basic to clinical research. She has extensive experience leading clinical trials and the development of methodologies in musculoskeletal measurement. Her particular focuses have been exercise interventions across the lifespan for bone health, and bone stress injuries in athlete and military populations. In recent years she developed the first effective exercise program for the prevention of osteoporotic fracture.
The impact and significance of her work are reflected in 108 peer-reviewed journal articles (80% Q1 journals, 83.3% in top 25% journals by CiteScore), 7 chapters and 16 consumer publications in her field. Over 35% of her publications are in the top 10% most viewed publications worldwide (SciVal).
She has supervised 11 PhD, 5 Masters and 13 Honours students to completion and is currently supervising 2 PhD students, 1 Masters and 1 Honours student, along with three research associates (fellows and assistants). She has delivered 40 invited presentations worldwide (e.g., London, Italy, France, Germany, and the USA) and 57 nationally. She is a Board member of the International Osteoporosis Foundation Capture the Fracture programme, Sports Medicine Australia, the Australian and New Zealand Bone and Mineral Society and a Fellow of the American Society of Bone and Mineral Research, the American College of Sports Medicine, Sports Medicine Australia and Exercise Sports Science Australia.
Dr Beck’s research impact stems from the results of successful and innovative clinical trials and methodological studies that have changed practice in the fields of osteoporosis and military medicine and research practice. The implementation of her research outcomes in the real world seek to make genuine and significant differences to the quality and productivity of people.
Source: Adapted from supplied copy
You Might also like
-
Cellular interactions responsible for development, maintenance, and strength of the skeleton
Professor Sims directs the Bone Cell Biology and Disease Unit at St. Vincent’s Institute of Medical Research and is a Professorial Fellow at The University of Melbourne and Australian Catholic University.
She leads a team who studies the cellular interactions responsible for development, maintenance, and strength of the skeleton. She completed her PhD at the University of Adelaide, followed by postdoctoral work at the Garvan Institute in Sydney then at Yale School of Medicine, in New Haven, Connecticut, where she studied the role of the estrogen receptor in regulating bone structure.
-
Unnecessary tests and treatments in low value critical care
Dr Gerben Keijzers is a Senior Staff Specialist Emergency Physician at the Gold Coast University Hospital Emergency Department. His research focus includes low-value care, which is in the area of unnecessary tests and treatments with minimal benefits. Dr Keijzers has contributed to over 100 publications and more than 20 grant applications. Through his involvement in multi-site collaborative research projects, he encourages critical thinking and curiosity among clinical staff, striving to enhance both patient care and the efficiency of healthcare resources.
-
Mechanisms of resistance to menin inhibitor therapy and Acute Myeloid Leukaemia
Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.